Kevin Kunzmann

An individualized model that provides vaccine-hesitant patients resources without compromising autonomy could aid efforts to limit the pandemic with new vaccines.

The longtime FDA expert assumes the role following the resignation of Stephen Hahn, MD.

The approval is the first indication for a new pathway of care—one which has been linked to reduced heart failure death and hospitalization.

Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.

Personalized, daily self-reporting for patients could influence future therapeutic strategies.

Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.

The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.

New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.

Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.

Both monotherapy and combination of the unique regimen was shown to improve manic and depressive status at 12 weeks.

The indication is the first of its kind for the rare, sometimes quickly fatal disease.

Results of a phase 3b trial suggest testosterone treatment could prevent the development of diabetes in men with low serum testosterone levels.

Primate model studies show the procedure can be done safely and without losing eye function. Which patients may benefit first?

A conversation on how associations between the chronic conditions have become better understood in 10 years.

Obese or overweight men participating in a lifestyle-based program had lower rates of diabetes after 2 years when also given testosterone therapy, a new study finds.

New one-year data makes history as the first to indicate the superiority of a one-injection gene therapy versus Factor VIII prophylaxis.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

The US currently leads all countries in total vaccine administrations as of the first week of 2021.

The global health agency provided current insights and advisories into 4 different variants recently identified during the ongoing pandemic.

To combat the deadliest cancer in the world, investigators are learning its origin in at-risk patients to prevent it altogether.

The first approved generic product for injection glucagon is also indicated for diagnostic use, when appropriate.

Despite the majority of frontline healthcare workers being women during the pandemic, television networks are infrequently featuring representative experts.

A discussion on how the public is still concerned with flu shot myths, and how it may influence COVID-19 vaccination and overall mitigation.

A discussion with a survey researcher on the 35% of US adults who state they won't get the vaccine this season.

Throughout the COVID-19 pandemic, the US has shown its lessening interest in mitigating the more manageable virus, influenza. Is there a chance to change course?

Long-term care facility residents and healthcare workers will receive the first of millions prepared doses in the US.

The VRBPAC committee voted 17-4, with 1 abstention, to support the benefit-risk profile of BNT162b2 for preventing COVID-19 in persons aged 16 years and older.

A continued conversation on the intricate, patient-centric benefits of care with the subcutaneous agent.

The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.

The historic phase 3 HOPE-B trial shows all but 1 treated patient discontinued prophylaxis after a single dose of etranacogene deaparvovec.